Arcutis Biotherapeutics Reports Inducement Grants Under : co

WESTLAKE VILLAGE, Calif., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early commercial-stage biopharmaceutical...

Related Keywords

Amanda Sheldon , Exchange Commission , Twitter , Facebook , Head Of Corporate Communications , Nasdaq , Compensation Committee Of Arcuti Board Directors , Arcutis Biotherapeutics Inc , Compensation Committee , Arcuti Board , Nasdaq Listing Rule , Nasdaq Arqt , Arcutis Biotherapeutics , Nc ,